Search research articles
Contact Us
Filters
Showing results (41-50 of 76) with videos related to
Page
of 8
Sort By:
Infection Control and Hospital Epidemiology
|
June 5, 2026
Discontinuing contact precautions for COVID-19: the science says its time
James M Jurica, Davey M Smith, Shira Abeles, et al.
Toxins
|
November 10, 2011
The potential contributions of lethal and edema toxins to the pathogenesis of anthrax associated shock
Caitlin W Hicks, Xizhong Cui, Daniel A Sweeney, et al.
Critical Care Medicine
|
March 26, 2009
Antithrombosis Trials: Should we test therapeutic heparin adjusted based on activated partial thromboplastin time in septic shock?
Amisha V Barochia, Yan Li, Xizhong Cui, et al.
Journal of Addiction Medicine
|
February 29, 2024
Temporal Trends in Methamphetamine Use in Patients Admitted to the Hospital: A Retrospective Cohort Study
Daniel J Suto, Jessica Xiao, Amy L Bellinghausen, et al.
Open Forum Infectious Diseases
|
November 29, 2019
Predictors of Acute Liver Failure in Patients With Acute Hepatitis A: An Analysis of the 2016-2018 San Diego County Hepatitis A Outbreak
Aiyang A Jiang, Holly S Greenwald, Lamiya Sheikh, et al.
Science Progress
|
October 30, 2023
Secondary infections in critically ill patients with COVID-19 receiving steroid therapy
Alex K Pearce, Qais Zawaydeh, W Cameron McGuire, et al.
Critical Care Medicine
|
September 20, 2011
Efficacy of selective mineralocorticoid and glucocorticoid agonists in canine septic shock
Caitlin W Hicks, Daniel A Sweeney, Robert L Danner, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 19, 2021
Deconstructing the Treatment Effect of Remdesivir in the Adaptive Coronavirus Disease 2019 (COVID-19) Treatment Trial-1: Implications for Critical Care Resource Utilization
Jonathan Fintzi, Tyler Bonnett, Daniel A Sweeney, et al.
The Journal of Infectious Diseases
|
November 12, 2010
Anthrax lethal and edema toxins produce different patterns of cardiovascular and renal dysfunction and synergistically decrease survival in canines
Daniel A Sweeney, Xizhong Cui, Steven B Solomon, et al.
Intensive Care Medicine
|
November 1, 2012
Beneficial effects of stress-dose corticosteroid therapy in canines depend on the severity of staphylococcal pneumonia
Caitlin W Hicks, Daniel A Sweeney, Robert L Danner, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 76) with videos related to
Sort By:
Page
of 8
Infection Control and Hospital Epidemiology
|
June 5, 2026
Discontinuing contact precautions for COVID-19: the science says its time
James M Jurica, Davey M Smith, Shira Abeles, et al.
Toxins
|
November 10, 2011
The potential contributions of lethal and edema toxins to the pathogenesis of anthrax associated shock
Caitlin W Hicks, Xizhong Cui, Daniel A Sweeney, et al.
Critical Care Medicine
|
March 26, 2009
Antithrombosis Trials: Should we test therapeutic heparin adjusted based on activated partial thromboplastin time in septic shock?
Amisha V Barochia, Yan Li, Xizhong Cui, et al.
Journal of Addiction Medicine
|
February 29, 2024
Temporal Trends in Methamphetamine Use in Patients Admitted to the Hospital: A Retrospective Cohort Study
Daniel J Suto, Jessica Xiao, Amy L Bellinghausen, et al.
Open Forum Infectious Diseases
|
November 29, 2019
Predictors of Acute Liver Failure in Patients With Acute Hepatitis A: An Analysis of the 2016-2018 San Diego County Hepatitis A Outbreak
Aiyang A Jiang, Holly S Greenwald, Lamiya Sheikh, et al.
Science Progress
|
October 30, 2023
Secondary infections in critically ill patients with COVID-19 receiving steroid therapy
Alex K Pearce, Qais Zawaydeh, W Cameron McGuire, et al.
Critical Care Medicine
|
September 20, 2011
Efficacy of selective mineralocorticoid and glucocorticoid agonists in canine septic shock
Caitlin W Hicks, Daniel A Sweeney, Robert L Danner, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 19, 2021
Deconstructing the Treatment Effect of Remdesivir in the Adaptive Coronavirus Disease 2019 (COVID-19) Treatment Trial-1: Implications for Critical Care Resource Utilization
Jonathan Fintzi, Tyler Bonnett, Daniel A Sweeney, et al.
The Journal of Infectious Diseases
|
November 12, 2010
Anthrax lethal and edema toxins produce different patterns of cardiovascular and renal dysfunction and synergistically decrease survival in canines
Daniel A Sweeney, Xizhong Cui, Steven B Solomon, et al.
Intensive Care Medicine
|
November 1, 2012
Beneficial effects of stress-dose corticosteroid therapy in canines depend on the severity of staphylococcal pneumonia
Caitlin W Hicks, Daniel A Sweeney, Robert L Danner, et al.
Page
of 8